Help researchers at the NIAID evaluate the safety and immune system response of a new Epstein-Barr virus vaccine. This research could help reduce future cases of mono.
Epstein-Barr virus (EBV) infects more than 90% of the world’s population, and when adolescents and young adults contract the virus they are at risk of experiencing serious health complications like developing mono or certain cancers. Currently, there is no vaccine that prevents or treats EBV infection.
Join researchers and help stop the spread of EBV! Participation in this research study may inform future treatments. Compensation provided up to $2220.